NYSE:ENZ

Enzo Biochem (ENZ) Stock Forecast, Price & News

$1.34

-0.05 (-3.60%)

(As of 09:30 AM ET)

Compare

Today's Range: $1.34
▼
$1.34
50-Day Range: $1.30
▼
$1.64
52-Week Range: $1.00
▼
$2.74

Volume: 1,270 shs
Average Volume: 439,887 shs
Market Capitalization: $66.54 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

About Enzo Biochem (NYSE:ENZ) Stock

Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. The Life Sciences Products segment develops, manufactures, and markets products and tools to clinical research, drug development, and bioscience research customers. It offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis. This segment also provides its products to scientific experts in the fields of cancer, cardiovascular disease, neurological disorders, diabetes and obesity, endocrine disorders, infectious and autoimmune disease, hepatotoxicity, and renal injury. The Clinical Laboratory Services segment provides molecular and other clinical laboratory tests or procedures used in general patient care by physicians to establish or support a diagnosis, monitor treatment or medication, and search for an otherwise undiagnosed condition. It operates a full-service clinical laboratory in Farmingdale, New York; a network of 30 patient service centers in New York and New Jersey; and a free-standing STAT' or rapid response laboratories in New York City and Connecticut, as well as a full-service phlebotomy center and an in-house logistics department. The Therapeutics segment develops novel approaches in the areas of gastrointestinal, infectious, ophthalmic, and metabolic diseases. It markets its products and services through its direct sales force and a network of distributors in the United States and internationally. The company was founded in 1976 and is headquartered in Farmingdale, New York.

ENZ Price History

30 days | 90 days | 365 days | Advanced Chart

ENZ Stock News Headlines

September 18, 2023 | finance.yahoo.com

Neurological Biomarkers Market to grow by USD 6.92 billion from 2022 to 2027 | North America to account for 43% of market growth- Technavio

September 11, 2023 | finance.yahoo.com

Neuroscience Antibodies and Assays Market to grow by USD 1.83 billion from 2022 to 2027, North America to account for 46% of market growth- Technavio

October 4, 2023 | Wall Street Fundamentals (Ad)

Would Buffett Approve of This Growth Strategy?

Warren Buffett's approach has been to find and invest in undervalued businesses with strong potential for growth. Taking this approach to heart and applying it to a Trillion Dollar industry has proved itself in a big way...achieving an incredible 400+% growth during a down market.

September 6, 2023 | marketwatch.com

Enzo Biochem CEO Hamid Erfanian Resigns After Two Years

September 6, 2023 | finance.yahoo.com

Enzo Biochem Announces Departure of Hamid Erfanian and Appointment of Kara Cannon as Interim CEO

August 25, 2023 | fool.com

Enzo Biochem (NYSE: ENZ)

July 31, 2023 | finance.yahoo.com

Here’s Why Laughing Water Capital Made a Position in Enzo Biochem (ENZ)

July 25, 2023 | finanznachrichten.de

Enzo Biochem, Inc.: Enzo Biochem Completes Sale of Clinical Laboratory to Labcorp

October 4, 2023 | Wall Street Fundamentals (Ad)

Would Buffett Approve of This Growth Strategy?

July 11, 2023 | seekingalpha.com

Enzo Biochem cuts price for labs assets to Labcorp

June 22, 2023 | benzinga.com

Short Volatility Alert: Enzo Biochem Inc

June 15, 2023 | finanznachrichten.de

Enzo Biochem, Inc.: Enzo Biochem Reports Third Quarter Fiscal Year 2023 Financial Results

June 15, 2023 | msn.com

Enzo Biochem reports Q3 results

June 14, 2023 | benzinga.com

Emerson Firm Investigates Enzo Biochem Data Breach

June 14, 2023 | finance.yahoo.com

Enzo Biochem Reports Third Quarter Fiscal Year 2023 Financial Results

June 8, 2023 | finance.yahoo.com

Enzo Biochem, Inc.'s (NYSE:ENZ) Popularity With Investors Is Under Threat From Overpricing

June 1, 2023 | yahoo.com

Enzo Biochem says ransomware attack exposed clinical test data of 2.5 million patients

May 31, 2023 | seekingalpha.com

Enzo Biochem says ransomware attack exposed patient info, Social Security numbers

May 22, 2023 | finanznachrichten.de

Enzo Biochem, Inc.: Enzo Biochem Reports Significant Progress towards Completing the Clinical Lab Asset Sale

May 22, 2023 | finance.yahoo.com

Enzo Biochem Reports Significant Progress towards Completing the Clinical Lab Asset Sale

May 14, 2023 | finance.yahoo.com

Enzo Biochem Insiders Added US$11m Of Stock To Their Holdings \

May 13, 2023 | marketwatch.com

Non-Alcoholic Steatohepatitis (NASH) Drugs Market Growth Forecast 2023-2031 with Size and Share

May 4, 2023 | marketwatch.com

Global Blood Screening Market by [2023-2029] with Revenue Outsourcing

May 3, 2023 | marketwatch.com

Wound Healing Assay Kits Market Analysis and Forecast to 2031

May 3, 2023 | benzinga.com

SHAREHOLDER ALERT: Weiss Law Investigates Enzo Biochem, Inc.

April 28, 2023 | marketwatch.com

2023-2030 Non-Radioactive Nucleic Acid Labeling Product Market Growth Developments with Latest Updates

April 28, 2023 | msn.com

Enzo Biochem in Farmingdale to Lay Off 247 Employees

See More Headlines

Receive ENZ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Enzo Biochem and its competitors with MarketBeat's FREE daily newsletter.

ENZ Company Calendar

Last Earnings: 10/15/2019
Today: 10/04/2023
Next Earnings (Estimated): 10/13/2023
Fiscal Year End: 7/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Medical laboratories
Sub-Industry: N/A
Sector: Medical
Current Symbol: NYSE:ENZ
CUSIP: N/A
CIK: 316253
Web: www.enzo.com
Phone: (212) 583-0100
Fax: 212-679-7999
Employees: 465
Year Founded: 1976

Profitability

EPS (Most Recent Fiscal Year): ($0.93)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-18,260,000.00
Net Margins: -64.19%
Pretax Margin: -64.19%
Return on Equity: -116.13%
Return on Assets: -53.28%

Debt

Debt-to-Equity Ratio: 0.01
Current Ratio: 0.76
Quick Ratio: 0.40

Sales & Book Value

Annual Sales: $107.07 million
Price / Sales: 0.64
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $1.12 per share
Price / Book: 1.22

Miscellaneous

Outstanding Shares: 49,660,000
Free Float: 41,965,000
Market Cap: $68.03 million
Optionable: Optionable
Beta: 0.96

Social Links

12 Stocks Corporate Insiders are Abandoning

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives

Ms. Kara Cannon (Age 54)
Interim CEO & COO
Comp: $474.28k

Dr. Elazar Rabbani Ph.D. (Age 80)
Co-Founder & Director
Comp: $3.23M

Ms. Patricia Eckert CPA (Age 46)
Interim Chief Financial Officer

Mr. Matthew Kupferberg (Age 57)
Gen. Counsel & Sec.

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

ENZ Stock - Frequently Asked Questions

How have ENZ shares performed in 2023?: Enzo Biochem's stock was trading at $1.43 at the beginning of 2023. Since then, ENZ stock has decreased by 4.2% and is now trading at $1.37.
View the best growth stocks for 2023 here.
Are investors shorting Enzo Biochem?: Enzo Biochem saw a increase in short interest during the month of September. As of September 15th, there was short interest totaling 1,670,000 shares, an increase of 13.6% from the August 31st total of 1,470,000 shares. Based on an average daily volume of 335,100 shares, the days-to-cover ratio is currently 5.0 days. Approximately 4.8% of the shares of the stock are short sold.
View Enzo Biochem's Short Interest.
When is Enzo Biochem's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Friday, October 13th 2023.
View our ENZ earnings forecast.
How were Enzo Biochem's earnings last quarter?: Enzo Biochem, Inc. (NYSE:ENZ) released its earnings results on Tuesday, October, 15th. The medical research company reported ($0.11) earnings per share for the quarter, beating the consensus estimate of ($0.14) by $0.03. The medical research company had revenue of $20.92 million for the quarter. Enzo Biochem had a negative trailing twelve-month return on equity of 116.13% and a negative net margin of 64.19%.
What other stocks do shareholders of Enzo Biochem own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Enzo Biochem investors own include OneLife Technologies (OLMM), Gilead Sciences (GILD), OPKO Health (OPK), Teva Pharmaceutical Industries (TEVA), Inovio Pharmaceuticals (INO), AbbVie (ABBV), Pfizer (PFE), Advanced Micro Devices (AMD), Amarin (AMRN) and Micron Technology (MU).

What is Enzo Biochem's stock symbol?: Enzo Biochem trades on the New York Stock Exchange (NYSE) under the ticker symbol "ENZ."
How do I buy shares of Enzo Biochem?: Shares of ENZ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Enzo Biochem's stock price today?: One share of ENZ stock can currently be purchased for approximately $1.37.
How much money does Enzo Biochem make?: Enzo Biochem (NYSE:ENZ) has a market capitalization of $68.03 million and generates $107.07 million in revenue each year. The medical research company earns $-18,260,000.00 in net income (profit) each year or ($0.93) on an earnings per share basis.
How many employees does Enzo Biochem have?: The company employs 465 workers across the globe.
How can I contact Enzo Biochem?: Enzo Biochem's mailing address is 527 Madison Ave., New York NY, 10022. The official website for the company is www.enzo.com. The medical research company can be reached via phone at (212) 583-0100, via email at ir@enzo.com, or via fax at 212-679-7999.

This page (NYSE:ENZ) was last updated on 10/4/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial